Mylan has become the first company to launch a generic version of GlaxoSmithKline's (GSK) big-selling respiratory drug Seretide in the UK. Seretide (salmeterol xinafoate/fluticasone propionate ...

Developed with US respiratory specialist firm Innoviva, the drug (known as Breo Ellipta in the US ... a long-acting beta2-agonist, in a single inhaler, the Ellipta. Sales of the drug are ...

Doctors could be taught to limit the use of traditional asthma inhalers due to their environmental impact. This initiative, led by the University of Glasgow and coordinated by the European ...

Excessive use of reliever inhalers for asthma is linked to a significantly increased risk of dying from the disease, a new study revealed today. Researchers found that over-use of short acting ...